Attention Deficit Hyperactivity Disorder Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Attention Deficit Hyperactivity Disorder stocks.

Attention Deficit Hyperactivity Disorder Stocks Recent News

Date Stock Title
May 5 LLY 3 Super-Safe Dividend Stocks That Have Been Making Recurring Payments for 130+ Years
May 5 LLY 3 No-Brainer Stocks to Buy in May
May 4 LLY Pharma R&D productivity seen improving for the first time in years - Deloitte
May 4 LLY Eli Lilly: Great Time To Divest Before It Potentially Crashes
May 4 LLY Move Over, Mounjaro. Eli Lilly Has Another Blockbuster in the Making
May 4 LLY Can Pfizer Challenge Lilly and Novo Nordisk in the Obesity Market?
May 4 LLY Eli Lilly Raised Its Outlook. Is the Stock a Buy Now?
May 3 LLY Amazon Stock Is on a Roll. Here’s Why It’s on This Firm’s ‘Best Ideas List.’
May 3 LLY Amgen's peek at its GLP-1 drug trial results heightens competition in obesity market
May 3 LLY Eli Lilly Remains Expensive Here - Minimal Margin Of Safety
May 3 LLY Analyst unveils Amgen stock price target after weight-loss drug data
May 3 LLY Amgen (AMGN) Q1 Earnings Top, Stock Up on Obesity Drug Update
May 3 LLY Weight-loss drug competition heats up. Is Wegovy in trouble?
May 3 LLY Pharma Stock Roundup: LLY, NVO, PFE Q1 Results, JNJ's New Plan to Resolve Talc Claims
May 3 LLY Amgen Knocks Novo Nordisk's Ozempic Stock Rally. Its Stock Is Flying.
May 3 LLY US STOCKS-Wall St set to open sharply higher on soft jobs data
May 3 LLY Amgen shares soar as executives outline obesity drug push
May 3 LLY US STOCKS-Futures rise on Apple, Amgen boost; jobs data awaited
May 3 LLY How the CFOs of Eli Lilly and Novo Nordisk are coping with ‘unprecedented demand’ for weight-loss drugs
May 3 LLY Eli Lilly: Don't Overpay For Miracle Drugs
Attention Deficit Hyperactivity Disorder

Attention deficit hyperactivity disorder (ADHD) is a mental disorder of the neurodevelopmental type. It is characterized by difficulty paying attention, excessive activity, or difficulty controlling behavior which is not appropriate for a person's age. The symptoms appear before a person is twelve years old, are present for more than six months, and may cause problems in at least two settings (such as school, home, or recreational activities). In children, problems paying attention may result in poor school performance. Additionally there is an association with other mental disorders and substance misuse. Although it causes impairment, particularly in modern society, many people with ADHD can have sustained attention span for tasks they find interesting or rewarding (known as hyperfocus).Despite being the most commonly studied and diagnosed mental disorder in children and adolescents, the exact cause is unknown in the majority of cases. It affects about 5–7% of children when diagnosed via the DSM-IV criteria and 1–2% when diagnosed via the ICD-10 criteria. As of 2015 it is estimated to affect about 51.1 million people globally. Rates are similar between countries and depend mostly on how it is diagnosed. ADHD is diagnosed approximately two times more often in boys than in girls, although the disorder is often overlooked in girls because their symptoms differ from those of boys. About 30–50% of people diagnosed in childhood continue to have symptoms into adulthood and between 2–5% of adults have the condition. In adults inner restlessness rather than hyperactivity may occur. The condition can be difficult to tell apart from other conditions, as well as to distinguish from high levels of activity that are still within the range of normative behaviors.ADHD management recommendations vary by country and usually involve some combination of counseling, lifestyle changes, and medications. The British guideline only recommends medications as a first-line treatment in children who have severe symptoms and for medication to be considered in those with moderate symptoms who either refuse or fail to improve with counseling, though for adults medications are a first-line treatment. Canadian and American guidelines recommend that medications and behavioral therapy be used together as a first-line therapy, except in preschool-aged children. Stimulant medication therapy is not recommended as a first-line therapy in preschool-aged children in either guideline. Treatment with stimulants is effective for at least 14 months; however, their long term effectiveness is unclear. Adults often develop coping skills which make up for some or all of their impairments.The medical literature has described symptoms similar to those of ADHD since the 18th century. ADHD, its diagnosis, and its treatment have been considered controversial since the 1970s. The controversies have involved clinicians, teachers, policymakers, parents, and the media. Topics include ADHD's causes and the use of stimulant medications in its treatment. Most healthcare providers accept ADHD as a genuine disorder in children and adults, and the debate in the scientific community mainly centers on how it is diagnosed and treated. The condition was officially known as attention-deficit disorder (ADD) from 1980 to 1987, while before this it was known as hyperkinetic reaction of childhood.

Browse All Tags